SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Caplin Point Laboratories informs about postal ballot notice

01 Jan 2019 Evaluate

Pursuant to Regulation 110 of the Companies Act, 2013 read with Companies (Management and Administration) Rules, 2014, Caplin Point Laboratories has informed that the approval of the Members of the company was sought for the Special resolution of transfer of business undertaking of the company (Regulated Markets injectable Business, including USFDA approved injectable plant and DSIR recognized R&D units CP4 & CP5) to its Wholly Owned Subsidiary company, by means of Postal Ballot including e-voting vide Postal Ballot Notice dated November 19, 2018. The details of combined voting results (e-voting and voting through Postal Ballot Forms) and report of the Scrutinizer are enclosed as Annexures.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Labs. Share Price

2622.50 64.10 (2.51%)
30-Jun-2026 12:39 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1865.60
Dr. Reddys Labs. 1360.90
Cipla 1477.80
Zydus Lifesciences 1122.60
Lupin 2410.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: